Cardiovascular diseases remain the leading cause of death among individuals worldwide. According to the World Health Organization (WHO), more than 17 million people die annually due to cardiovascular disease.

This is a serious concern as prevention and early treatment can be effective in reducing the risks and fatalities related to heart conditions. With the COVID-19 pandemic affecting healthcare access, it is more important than ever to identify individuals who are at high risk of developing cardiovascular complications. This is where WorldRisk comes in.

What is WorldRisk?

WorldRisk is an innovative cardiovascular risk prediction tool that assesses an individual’s risk of developing cardiovascular complications.

Developed by Novartis Pharma AG, WorldRisk uses data from the largest global study of cardiovascular disease risk factors, including more than 200,000 patients from 50 countries.

How Does WorldRisk Work?

WorldRisk utilizes a combination of traditional and non-traditional risk factors to evaluate an individual’s cardiovascular risk score. Traditional risk factors like age, gender, blood pressure, and cholesterol levels are taken into account.

However, the tool also uses other factors like family history, body mass index (BMI), and socioeconomic factors to assess the individual’s likelihood of developing cardiovascular complications.

WorldRisk Across Different Parts of the World

One of the crucial aspects of WorldRisk is its ability to predict cardiovascular risks in different parts of the world accurately.

The study results indicate that there are significant regional variations in cardiovascular risk factors, and WorldRisk considers these differences in its calculations.

North America

Cardiovascular disease risk factors differ throughout North America, with Americans having a higher risk than Canadians. This difference is partly due to differences in lifestyles and diets.

The prevalence of smoking also varies significantly between the two countries, with the US having a higher percentage of smokers. WorldRisk takes these factors into account when assessing an individual’s cardiovascular risk score.

Europe

Cardiovascular disease remains the leading cause of death in Europe, with around 4.3 million deaths annually. However, there is a significant difference in cardiovascular disease prevalence between western and eastern Europe.

The prevalence of cardiovascular complications is higher in the east, and this is partly due to differences in lifestyles and healthcare access. WorldRisk considers these regional differences to provide accurate risk assessment across Europe.

Asia

Asia has the highest prevalence of cardiovascular disease globally, with factors such as hypertension, diabetes, and obesity contributing significantly to the burden.

WorldRisk considers these factors along with smoking and physical inactivity to provide an accurate risk assessment for individuals in Asia.

Africa

The prevalence of cardiovascular disease in Africa has been on the rise in recent years, with hypertension and cholesterol levels being the significant risk factors.

Poor lifestyle choices and limited healthcare access are other factors that contribute to the prevalence of cardiovascular complications in Africa. WorldRisk takes these factors into account to provide African individuals with an accurate cardiovascular risk score.

Australia

Australia has one of the highest rates of cardiovascular disease globally, with an estimated 17 million Australians having at least one risk factor.

WorldRisk considers both traditional and non-traditional risk factors, including smoking, physical inactivity, and dietary habits to assess an individual’s cardiovascular risk score.

Benefits of using WorldRisk

WorldRisk offers several benefits for individuals at risk of developing cardiovascular complications. These include:.

Accurate cardiovascular risk assessment using a combination of traditional and non-traditional risk factors
Regional risk assessment across the globe, taking into account regional variations in risk factors
Early identification of individuals at high risk of developing cardiovascular complications, enabling timely intervention
Informed decision-making for healthcare professionals and patients regarding prevention and early treatment

Conclusion

Cardiovascular disease continues to be a significant global health concern, and identifying individuals at high risk of developing cardiovascular complications is essential for prevention and early treatment.

WorldRisk offers a comprehensive cardiovascular risk prediction tool that takes regional variations in risk factors into account. With timely intervention, it is possible to reduce the risks and fatalities associated with heart conditions.